Celadon Pharmaceuticals PLC (CEL) — Defensive Interval Ratio
Celadon Pharmaceuticals PLC (CEL) has a Defensive Interval Ratio of -83 days as of June 2024. Defensive assets of GBX-199.00K (cash GBX-, short-term investments GBX-272.00K, receivables GBX73.00K) cover -83 days of daily cash needs of GBX2.41K/day. See Celadon Pharmaceuticals PLC short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Celadon Pharmaceuticals PLC Defensive Interval Ratio (2019–2023)
This chart shows how Celadon Pharmaceuticals PLC's Defensive Interval Ratio has evolved across 5 annual periods from 2019 to 2023. As of June 2024, the ratio stands at -83 days, meaning defensive assets of GBX-199.00K can fund -83 days of operations without new revenue. See Celadon Pharmaceuticals PLC balance sheet independence to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for Celadon Pharmaceuticals PLC (2019–2023)
The table below presents the year-by-year Defensive Interval Ratio for Celadon Pharmaceuticals PLC from 2019 to 2023, covering 5 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see Celadon Pharmaceuticals PLC (CEL) market capitalisation.
| Year | DIR (days) | Defensive Assets (GBX) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2023 | 29 days | GBX75.00K | GBX2.62K/day | GBX- | GBX- | ▼ -295 days |
| 2022 | 324 days | GBX1.06 Million | GBX3.28K/day | GBX- | GBX- | ▼ -4080 days |
| 2021 | 4404 days | GBX2.13 Million | GBX484.74/day | GBX- | GBX- | ▲ +4403 days |
| 2020 | 0 days | GBX599.00 | GBX2.29K/day | GBX- | GBX- | ▼ -1 days |
| 2019 | 2 days | GBX300.00 | GBX183.08/day | GBX- | GBX- | — |